Kidswell Bio Corporation (TYO:4584)
148.00
-2.00 (-1.33%)
Jun 3, 2026, 3:30 PM JST
Kidswell Bio Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Cash & Equivalents | 3,294 | 2,995 | 1,187 | 1,461 | 2,032 |
Cash & Short-Term Investments | 3,294 | 2,995 | 1,187 | 1,461 | 2,032 |
Cash Growth | 9.98% | 152.32% | -18.75% | -28.10% | 1.13% |
Accounts Receivable | 731 | 1,267 | 461 | 816 | 651 |
Other Receivables | 141 | 50 | - | - | - |
Receivables | 872 | 1,317 | 461 | 816 | 651 |
Inventory | 363 | 1,475 | 988 | 450 | 254 |
Prepaid Expenses | 6 | 16 | - | - | - |
Other Current Assets | 1,305 | 897 | 689 | 619 | 385 |
Total Current Assets | 5,840 | 6,700 | 3,325 | 3,346 | 3,322 |
Property, Plant & Equipment | 17 | 1 | 1 | 3 | 1 |
Long-Term Investments | 229 | 305 | 172 | 581 | 267 |
Other Intangible Assets | - | - | 3 | 2 | - |
Other Long-Term Assets | 2 | 2 | 2 | 1 | 2 |
Total Assets | 6,088 | 7,008 | 3,503 | 3,933 | 3,592 |
Accounts Payable | - | 226 | 45 | 109 | 8 |
Short-Term Debt | - | - | - | - | 25 |
Current Portion of Long-Term Debt | 362 | 657 | 75 | - | - |
Current Income Taxes Payable | 655 | 453 | 297 | 396 | 255 |
Other Current Liabilities | 1,132 | 2,982 | 711 | 609 | 592 |
Total Current Liabilities | 2,149 | 4,318 | 1,128 | 1,114 | 880 |
Long-Term Debt | 2,187 | 1,180 | 625 | 1,100 | 1,200 |
Pension & Post-Retirement Benefits | 57 | 41 | 31 | 19 | 19 |
Long-Term Deferred Tax Liabilities | 39 | 56 | - | 89 | - |
Other Long-Term Liabilities | 4 | 4 | 2 | 2 | 6 |
Total Liabilities | 4,436 | 5,599 | 1,786 | 2,324 | 2,105 |
Common Stock | 191 | 2,317 | 1,421 | 1,032 | 611 |
Additional Paid-In Capital | 2,566 | 11,623 | 10,726 | 10,337 | 9,917 |
Retained Earnings | -1,241 | -12,730 | -10,613 | -10,078 | -9,077 |
Comprehensive Income & Other | 136 | 199 | 183 | 318 | 36 |
Shareholders' Equity | 1,652 | 1,409 | 1,717 | 1,609 | 1,487 |
Total Liabilities & Equity | 6,088 | 7,008 | 3,503 | 3,933 | 3,592 |
Total Debt | 2,549 | 1,837 | 700 | 1,100 | 1,225 |
Net Cash (Debt) | 745 | 1,158 | 487 | 361 | 807 |
Net Cash Growth | -35.66% | 137.78% | 34.90% | -55.27% | -59.84% |
Net Cash Per Share | 15.27 | 28.59 | 15.79 | 12.54 | 29.19 |
Filing Date Shares Outstanding | 49.6 | 47.63 | 31.44 | 29.94 | 28.73 |
Total Common Shares Outstanding | 49.6 | 43.88 | 31.44 | 29.62 | 27.65 |
Working Capital | 3,691 | 2,382 | 2,197 | 2,232 | 2,442 |
Book Value Per Share | 33.31 | 32.11 | 54.62 | 54.32 | 53.79 |
Tangible Book Value | 1,652 | 1,409 | 1,714 | 1,607 | 1,487 |
Tangible Book Value Per Share | 33.31 | 32.11 | 54.52 | 54.25 | 53.79 |